Elanco Animal Health Incorporated (NYSE: ELAN) is -21.11% lower on its value in year-to-date trading and has touched a low of $9.02 and a high of $27.68 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ELAN stock was last observed hovering at around $9.45 in the last trading session, with the day’s gains setting it 0.19% off its average median price target of $14.50 for the next 12 months. It is also 51.8% off the consensus price target high of $20.00 offered by 12 analysts, but current levels are 8.19% higher than the price target low of $10.50 for the same period.
Currently trading at $9.64, the stock is -13.82% and -22.43% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 7.93 million and changing 2.01% at the moment leaves the stock -36.36% off its SMA200. ELAN registered -62.15% loss for a year compared to 6-month loss of -37.52%.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
The stock witnessed a -25.21% gain in the last 1 month and extending the period to 3 months gives it a -26.30%, and is -4.65% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.00% over the week and 4.21% over the month.
Elanco Animal Health Incorporated (ELAN) has around 9000 employees, a market worth around $5.01B and $4.41B in sales. Fwd P/E is 10.35. Profit margin for the company is -1.80%. Distance from 52-week low is 6.81% and -65.17% from its 52-week high. The company has generated returns on investments over the last 12 months (1.50%).
Elanco Animal Health Incorporated (ELAN) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for Elanco Animal Health Incorporated (ELAN) is a “Hold”. 12 analysts offering their recommendations for the stock have an average rating of 2.80, where 8 rate it as a Hold and 0 think it is a “Overweight”. 3 of the analysts rate the stock as a “Buy”. 1 analysts have rated the stock as a Sell or Underperform.
Elanco Animal Health Incorporated is expected to release its quarterly report on 05/08/2023.The EPS is expected to grow by 83.90% this year
Elanco Animal Health Incorporated (ELAN) Top Institutional Holders
The shares outstanding are 488.30M, and float is at 472.91M with Short Float at 2.95%.
Elanco Animal Health Incorporated (ELAN) Insider Activity
A total of 14 insider transactions have happened at Elanco Animal Health Incorporated (ELAN) in the last six months, with sales accounting for 2 and purchases happening 12 times. The most recent transaction is an insider purchase by HOOVER R DAVID, the company’s Director. SEC filings show that HOOVER R DAVID bought 5,000 shares of the company’s common stock on Mar 14 at a price of $9.55 per share for a total of $47750.0. Following the purchase, the insider now owns 0.17 million shares.
Elanco Animal Health Incorporated disclosed in a document filed with the SEC on Mar 13 that HOOVER R DAVID (Director) bought a total of 5,000 shares of the company’s common stock. The trade occurred on Mar 13 and was made at $9.46 per share for $47288.0. Following the transaction, the insider now directly holds 0.16 million shares of the ELAN stock.
Still, SEC filings show that on Mar 10, Simmons Jeffrey N (PRESIDENT, CEO AND DIRECTOR) acquired 15,000 shares at an average price of $9.60 for $0.14 million. The insider now directly holds 45,000 shares of Elanco Animal Health Incorporated (ELAN).